CompletedNot Applicable

Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

Spain120 participantsStarted 2022-06-15

Plain-language summary

HBV infection is a dynamic process with complex interactions between virus replication and the host's immune response. The appearance of anti-HBs after HBV infection generally indicates recovery and immunity to HBV1 infection. However, there are several published studies that describe the coexistence of the marker of chronic infection (HBsAg +) and the marker of functional cure (HBsAc +). There are contradictory studies on whether the coexistence of HBsAg/HBsAc implies a different clinical course.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all those patients who have been seen in outpatient hepatology consultations and who present positive HBsAg and HBsAc serology simultaneously. Exclusion Criteria: * Hepatitis C or HIV Co-infection

What they're measuring

prevalence concomitant HBsAg and HBsAc markers

Timeframe: 10 years

Trial details

NCT IDNCT05446532

SponsorCorporacion Parc Tauli

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-31

View on ClinicalTrials.gov More Hepatitis B trials